tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
STRO is currently covered by 6 analysts with an average price target of $46.09. This is a potential upside of $30.74 (200.26%) from yesterday's end of day stock price of $15.35.
Sutro Biopharma's activity chart (see below) currently has 76 price targets and 91 ratings on display. The stock rating distribution of STRO is 71.43% BUY and 28.57% HOLD.
Analysts average stock forecasts to be materialized ratio is 64.63% with an average time for these price targets to be met of 412.92 days.
Highest price target for STRO is $60, Lowest price target is $23, average price target is $46.09.
Most recent stock forecast was given by DEREK ARCHILA from WELLS FARGO. First documented stock forecast 22-Oct-2018.
Currently out of the existing stock ratings of STRO, 10 are a BUY (71.43%), 4 are a HOLD (28.57%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Sep-2026
$49
$33.65 (219.22%)
$3
Buy Since 13-Aug-2026
$60
$44.65 (290.88%)
$60
1 months 22 days ago
(13-Aug-2026)
6/11 (54.55%)
$38.69 (181.56%)
681
Buy Since 17-Apr-2026
$34
$18.65 (121.50%)
$41
1 months 22 days ago
(13-Aug-2026)
12/14 (85.71%)
$12.69 (59.55%)
370
Buy Since 13-Jan-2020
$50
$19.48 (63.83%)
3 months 24 days ago
(11-Jun-2026)
7/8 (87.5%)
$23.52 (88.82%)
599
Buy Since 15-May-2026
$50
$34.65 (225.73%)
$28
4 months 20 days ago
(15-May-2026)
2/3 (66.67%)
$11.03 (28.30%)
162
What is STRO (Sutro Biopharma) average time for price targets to be met?
Which analyst most recently updated their price target on STRO (Sutro Biopharma)?
Which analyst has the most public recommendations on STRO (Sutro Biopharma)?
Which analyst is the currently most bullish on STRO (Sutro Biopharma)?
Which analyst is the currently most reserved on STRO (Sutro Biopharma)?
